Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Onconetix (ONCO) Return on Equity (2023 - 2025)

Historic Return on Equity for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to 10.59%.

  • Onconetix's Return on Equity fell 21900.0% to 10.59% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.59%, marking a year-over-year decrease of 21900.0%. This contributed to the annual value of 11.8% for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Onconetix's Return on Equity is 10.59%, which was down 21900.0% from 8.92% recorded in Q2 2025.
  • Onconetix's 5-year Return on Equity high stood at 6.98% for Q1 2024, and its period low was 10.59% during Q3 2025.
  • For the 3-year period, Onconetix's Return on Equity averaged around 4.53%, with its median value being 7.41% (2023).
  • Per our database at Business Quant, Onconetix's Return on Equity surged by 40600bps in 2024 and then plummeted by -159300bps in 2025.
  • Quarter analysis of 3 years shows Onconetix's Return on Equity stood at 6.43% in 2023, then surged by 63bps to 2.37% in 2024, then plummeted by -347bps to 10.59% in 2025.
  • Its Return on Equity stands at 10.59% for Q3 2025, versus 8.92% for Q2 2025 and 8.95% for Q1 2025.